this only represents buying opportunity. if they can keep up with their FY18 growth rate in FY19, i believe they will be NPAT positive and 14c will be low teens PE at FY19 year end...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025